世界の前立腺特異抗原（PSA）検査市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Prostate-Specific Antigen (PSA) Test Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z11555
• 出版社/出版日：GlobalInfoResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、102ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料では、前立腺特異抗原（PSA）検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。前立腺特異抗原（PSA）検査の種類別市場規模（CLIA、ELISA、その他）、用途別市場規模（スクリーニング、治療後モニタリング、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・前立腺特異抗原（PSA）検査の市場概要
・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott、Siemens Healthcare、DiaSorin、Roche、Beckman Coulter、PerkinElmer、Tosoh、Ortho Clinical、Fujirebio、Mediwatch (LABORIE)、BodiTech
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年：CLIA、ELISA、その他
・用途別分析2016年-2026年：スクリーニング、治療後モニタリング、その他
・前立腺特異抗原（PSA）検査の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ
・前立腺特異抗原（PSA）検査のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア
・前立腺特異抗原（PSA）検査のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア
・前立腺特異抗原（PSA）検査の南米市場規模2016年-2026年：ブラジル、アルゼンチン
・前立腺特異抗原（PSA）検査の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Prostate-Specific Antigen (PSA) Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Prostate-Specific Antigen (PSA) Test size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Prostate-Specific Antigen (PSA) Test market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Prostate-Specific Antigen (PSA) Test market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
CLIA
ELISA
Other

Market segment by Application, can be divided into
Screening
Post-treatment Monitoring
Other

Market segment by players, this report covers
Abbott
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch (LABORIE)
BodiTech

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Prostate-Specific Antigen (PSA) Test
1.2 Classification of Prostate-Specific Antigen (PSA) Test by Type
1.2.1 Overview: Global Prostate-Specific Antigen (PSA) Test Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Type in 2020
1.2.3 CLIA
1.2.4 ELISA
1.2.5 Other
1.3 Global Prostate-Specific Antigen (PSA) Test Market by Application
1.3.1 Overview: Global Prostate-Specific Antigen (PSA) Test Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Screening
1.3.3 Post-treatment Monitoring
1.3.4 Other
1.4 Global Prostate-Specific Antigen (PSA) Test Market Size & Forecast
1.5 Global Prostate-Specific Antigen (PSA) Test Market Size and Forecast by Region
1.5.1 Global Prostate-Specific Antigen (PSA) Test Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Prostate-Specific Antigen (PSA) Test Market Size by Region, (2016-2021)
1.5.3 North America Prostate-Specific Antigen (PSA) Test Market Size and Prospect (2016-2026)
1.5.4 Europe Prostate-Specific Antigen (PSA) Test Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size and Prospect (2016-2026)
1.5.6 South America Prostate-Specific Antigen (PSA) Test Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Prostate-Specific Antigen (PSA) Test Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Prostate-Specific Antigen (PSA) Test Market Drivers
1.6.2 Prostate-Specific Antigen (PSA) Test Market Restraints
1.6.3 Prostate-Specific Antigen (PSA) Test Trends Analysis
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Prostate-Specific Antigen (PSA) Test Product and Solutions
2.1.4 Abbott Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Siemens Healthcare
2.2.1 Siemens Healthcare Details
2.2.2 Siemens Healthcare Major Business
2.2.3 Siemens Healthcare Prostate-Specific Antigen (PSA) Test Product and Solutions
2.2.4 Siemens Healthcare Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Siemens Healthcare Recent Developments and Future Plans
2.3 DiaSorin
2.3.1 DiaSorin Details
2.3.2 DiaSorin Major Business
2.3.3 DiaSorin Prostate-Specific Antigen (PSA) Test Product and Solutions
2.3.4 DiaSorin Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 DiaSorin Recent Developments and Future Plans
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Prostate-Specific Antigen (PSA) Test Product and Solutions
2.4.4 Roche Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Roche Recent Developments and Future Plans
2.5 Beckman Coulter
2.5.1 Beckman Coulter Details
2.5.2 Beckman Coulter Major Business
2.5.3 Beckman Coulter Prostate-Specific Antigen (PSA) Test Product and Solutions
2.5.4 Beckman Coulter Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Beckman Coulter Recent Developments and Future Plans
2.6 PerkinElmer
2.6.1 PerkinElmer Details
2.6.2 PerkinElmer Major Business
2.6.3 PerkinElmer Prostate-Specific Antigen (PSA) Test Product and Solutions
2.6.4 PerkinElmer Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 PerkinElmer Recent Developments and Future Plans
2.7 Tosoh
2.7.1 Tosoh Details
2.7.2 Tosoh Major Business
2.7.3 Tosoh Prostate-Specific Antigen (PSA) Test Product and Solutions
2.7.4 Tosoh Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Tosoh Recent Developments and Future Plans
2.8 Ortho Clinical
2.8.1 Ortho Clinical Details
2.8.2 Ortho Clinical Major Business
2.8.3 Ortho Clinical Prostate-Specific Antigen (PSA) Test Product and Solutions
2.8.4 Ortho Clinical Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Ortho Clinical Recent Developments and Future Plans
2.9 Fujirebio
2.9.1 Fujirebio Details
2.9.2 Fujirebio Major Business
2.9.3 Fujirebio Prostate-Specific Antigen (PSA) Test Product and Solutions
2.9.4 Fujirebio Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Fujirebio Recent Developments and Future Plans
2.10 Mediwatch (LABORIE)
2.10.1 Mediwatch (LABORIE) Details
2.10.2 Mediwatch (LABORIE) Major Business
2.10.3 Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Product and Solutions
2.10.4 Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Mediwatch (LABORIE) Recent Developments and Future Plans
2.11 BodiTech
2.11.1 BodiTech Details
2.11.2 BodiTech Major Business
2.11.3 BodiTech Prostate-Specific Antigen (PSA) Test Product and Solutions
2.11.4 BodiTech Prostate-Specific Antigen (PSA) Test Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 BodiTech Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Prostate-Specific Antigen (PSA) Test Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Prostate-Specific Antigen (PSA) Test Players Market Share
3.2.2 Top 10 Prostate-Specific Antigen (PSA) Test Players Market Share
3.2.3 Market Competition Trend
3.3 Prostate-Specific Antigen (PSA) Test Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Prostate-Specific Antigen (PSA) Test Revenue and Market Share by Type (2016-2021)
4.2 Global Prostate-Specific Antigen (PSA) Test Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Application (2016-2021)
5.2 Prostate-Specific Antigen (PSA) Test Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Prostate-Specific Antigen (PSA) Test Revenue by Type (2016-2026)
6.2 North America Prostate-Specific Antigen (PSA) Test Revenue by Application (2016-2026)
6.3 North America Prostate-Specific Antigen (PSA) Test Market Size by Country
6.3.1 North America Prostate-Specific Antigen (PSA) Test Revenue by Country (2016-2026)
6.3.2 United States Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)
6.3.3 Canada Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)
6.3.4 Mexico Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Prostate-Specific Antigen (PSA) Test Revenue by Type (2016-2026)
7.2 Europe Prostate-Specific Antigen (PSA) Test Revenue by Application (2016-2026)
7.3 Europe Prostate-Specific Antigen (PSA) Test Market Size by Country
7.3.1 Europe Prostate-Specific Antigen (PSA) Test Revenue by Country (2016-2026)
7.3.2 Germany Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)
7.3.3 France Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)
7.3.5 Russia Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)
7.3.6 Italy Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Prostate-Specific Antigen (PSA) Test Revenue by Type (2016-2026)
8.2 Asia-Pacific Prostate-Specific Antigen (PSA) Test Revenue by Application (2016-2026)
8.3 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Region
8.3.1 Asia-Pacific Prostate-Specific Antigen (PSA) Test Revenue by Region (2016-2026)
8.3.2 China Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)
8.3.3 Japan Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)
8.3.4 South Korea Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)
8.3.5 India Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)
8.3.7 Australia Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Prostate-Specific Antigen (PSA) Test Revenue by Type (2016-2026)
9.2 South America Prostate-Specific Antigen (PSA) Test Revenue by Application (2016-2026)
9.3 South America Prostate-Specific Antigen (PSA) Test Market Size by Country
9.3.1 South America Prostate-Specific Antigen (PSA) Test Revenue by Country (2016-2026)
9.3.2 Brazil Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)
9.3.3 Argentina Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Prostate-Specific Antigen (PSA) Test Revenue by Type (2016-2026)
10.2 Middle East & Africa Prostate-Specific Antigen (PSA) Test Revenue by Application (2016-2026)
10.3 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Country
10.3.1 Middle East & Africa Prostate-Specific Antigen (PSA) Test Revenue by Country (2016-2026)
10.3.2 Turkey Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)
10.3.4 UAE Prostate-Specific Antigen (PSA) Test Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Prostate-Specific Antigen (PSA) Test Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Prostate-Specific Antigen (PSA) Test Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Prostate-Specific Antigen (PSA) Test Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Prostate-Specific Antigen (PSA) Test Revenue (USD Million) by Region (2016-2021)
Table 5. Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Region (2021-2026)
Table 6. Abbott Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Major Business
Table 8. Abbott Prostate-Specific Antigen (PSA) Test Product and Solutions
Table 9. Abbott Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Siemens Healthcare Corporate Information, Head Office, and Major Competitors
Table 11. Siemens Healthcare Major Business
Table 12. Siemens Healthcare Prostate-Specific Antigen (PSA) Test Product and Solutions
Table 13. Siemens Healthcare Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. DiaSorin Corporate Information, Head Office, and Major Competitors
Table 15. DiaSorin Major Business
Table 16. DiaSorin Prostate-Specific Antigen (PSA) Test Product and Solutions
Table 17. DiaSorin Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Roche Corporate Information, Head Office, and Major Competitors
Table 19. Roche Major Business
Table 20. Roche Prostate-Specific Antigen (PSA) Test Product and Solutions
Table 21. Roche Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Beckman Coulter Corporate Information, Head Office, and Major Competitors
Table 23. Beckman Coulter Major Business
Table 24. Beckman Coulter Prostate-Specific Antigen (PSA) Test Product and Solutions
Table 25. Beckman Coulter Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. PerkinElmer Corporate Information, Head Office, and Major Competitors
Table 27. PerkinElmer Major Business
Table 28. PerkinElmer Prostate-Specific Antigen (PSA) Test Product and Solutions
Table 29. PerkinElmer Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Tosoh Corporate Information, Head Office, and Major Competitors
Table 31. Tosoh Major Business
Table 32. Tosoh Prostate-Specific Antigen (PSA) Test Product and Solutions
Table 33. Tosoh Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Ortho Clinical Corporate Information, Head Office, and Major Competitors
Table 35. Ortho Clinical Major Business
Table 36. Ortho Clinical Prostate-Specific Antigen (PSA) Test Product and Solutions
Table 37. Ortho Clinical Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Fujirebio Corporate Information, Head Office, and Major Competitors
Table 39. Fujirebio Major Business
Table 40. Fujirebio Prostate-Specific Antigen (PSA) Test Product and Solutions
Table 41. Fujirebio Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Mediwatch (LABORIE) Corporate Information, Head Office, and Major Competitors
Table 43. Mediwatch (LABORIE) Major Business
Table 44. Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Product and Solutions
Table 45. Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. BodiTech Corporate Information, Head Office, and Major Competitors
Table 47. BodiTech Major Business
Table 48. BodiTech Prostate-Specific Antigen (PSA) Test Product and Solutions
Table 49. BodiTech Prostate-Specific Antigen (PSA) Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Global Prostate-Specific Antigen (PSA) Test Revenue (USD Million) by Players (2019-2021)
Table 51. Global Prostate-Specific Antigen (PSA) Test Revenue Share by Players (2019-2021)
Table 52. Breakdown of Prostate-Specific Antigen (PSA) Test by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Prostate-Specific Antigen (PSA) Test Players Head Office, Products and Services Provided
Table 54. Prostate-Specific Antigen (PSA) Test Mergers & Acquisitions in the Past Five Years
Table 55. Prostate-Specific Antigen (PSA) Test New Entrants and Expansion Plans
Table 56. Global Prostate-Specific Antigen (PSA) Test Revenue (USD Million) by Type (2016-2021)
Table 57. Global Prostate-Specific Antigen (PSA) Test Revenue Share by Type (2016-2021)
Table 58. Global Prostate-Specific Antigen (PSA) Test Revenue Forecast by Type (2021-2026)
Table 59. Global Prostate-Specific Antigen (PSA) Test Revenue by Application (2016-2021)
Table 60. Global Prostate-Specific Antigen (PSA) Test Revenue Forecast by Application (2021-2026)
Table 61. North America Prostate-Specific Antigen (PSA) Test Revenue by Type (2016-2021) & (USD Million)
Table 62. North America Prostate-Specific Antigen (PSA) Test Revenue by Type (2021-2026) & (USD Million)
Table 63. North America Prostate-Specific Antigen (PSA) Test Revenue by Application (2016-2021) & (USD Million)
Table 64. North America Prostate-Specific Antigen (PSA) Test Revenue by Application (2021-2026) & (USD Million)
Table 65. North America Prostate-Specific Antigen (PSA) Test Revenue by Country (2016-2021) & (USD Million)
Table 66. North America Prostate-Specific Antigen (PSA) Test Revenue by Country (2021-2026) & (USD Million)
Table 67. Europe Prostate-Specific Antigen (PSA) Test Revenue by Type (2016-2021) & (USD Million)
Table 68. Europe Prostate-Specific Antigen (PSA) Test Revenue by Type (2021-2026) & (USD Million)
Table 69. Europe Prostate-Specific Antigen (PSA) Test Revenue by Application (2016-2021) & (USD Million)
Table 70. Europe Prostate-Specific Antigen (PSA) Test Revenue by Application (2021-2026) & (USD Million)
Table 71. Europe Prostate-Specific Antigen (PSA) Test Revenue by Country (2016-2021) & (USD Million)
Table 72. Europe Prostate-Specific Antigen (PSA) Test Revenue by Country (2021-2026) & (USD Million)
Table 73. Asia-Pacific Prostate-Specific Antigen (PSA) Test Revenue by Type (2016-2021) & (USD Million)
Table 74. Asia-Pacific Prostate-Specific Antigen (PSA) Test Revenue by Type (2021-2026) & (USD Million)
Table 75. Asia-Pacific Prostate-Specific Antigen (PSA) Test Revenue by Application (2016-2021) & (USD Million)
Table 76. Asia-Pacific Prostate-Specific Antigen (PSA) Test Revenue by Application (2021-2026) & (USD Million)
Table 77. Asia-Pacific Prostate-Specific Antigen (PSA) Test Revenue by Region (2016-2021) & (USD Million)
Table 78. Asia-Pacific Prostate-Specific Antigen (PSA) Test Revenue by Region (2021-2026) & (USD Million)
Table 79. South America Prostate-Specific Antigen (PSA) Test Revenue by Type (2016-2021) & (USD Million)
Table 80. South America Prostate-Specific Antigen (PSA) Test Revenue by Type (2021-2026) & (USD Million)
Table 81. South America Prostate-Specific Antigen (PSA) Test Revenue by Application (2016-2021) & (USD Million)
Table 82. South America Prostate-Specific Antigen (PSA) Test Revenue by Application (2021-2026) & (USD Million)
Table 83. South America Prostate-Specific Antigen (PSA) Test Revenue by Country (2016-2021) & (USD Million)
Table 84. South America Prostate-Specific Antigen (PSA) Test Revenue by Country (2021-2026) & (USD Million)
Table 85. Middle East & Africa Prostate-Specific Antigen (PSA) Test Revenue by Type (2016-2021) & (USD Million)
Table 86. Middle East & Africa Prostate-Specific Antigen (PSA) Test Revenue by Type (2021-2026) & (USD Million)
Table 87. Middle East & Africa Prostate-Specific Antigen (PSA) Test Revenue by Application (2016-2021) & (USD Million)
Table 88. Middle East & Africa Prostate-Specific Antigen (PSA) Test Revenue by Application (2021-2026) & (USD Million)
Table 89. Middle East & Africa Prostate-Specific Antigen (PSA) Test Revenue by Country (2016-2021) & (USD Million)
Table 90. Middle East & Africa Prostate-Specific Antigen (PSA) Test Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Prostate-Specific Antigen (PSA) Test Picture
Figure 2. Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Type in 2020
Figure 3. CLIA
Figure 4. ELISA
Figure 5. Other
Figure 6. Prostate-Specific Antigen (PSA) Test Revenue Market Share by Application in 2020
Figure 7. Screening Picture
Figure 8. Post-treatment Monitoring Picture
Figure 9. Other Picture
Figure 10. Global Prostate-Specific Antigen (PSA) Test Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Prostate-Specific Antigen (PSA) Test Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Region (2016-2026)
Figure 13. Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Region in 2020
Figure 14. North America Prostate-Specific Antigen (PSA) Test Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Prostate-Specific Antigen (PSA) Test Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Prostate-Specific Antigen (PSA) Test Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Prostate-Specific Antigen (PSA) Test Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Prostate-Specific Antigen (PSA) Test Market Drivers
Figure 19. Prostate-Specific Antigen (PSA) Test Market Restraints
Figure 20. Prostate-Specific Antigen (PSA) Test Market Trends
Figure 21. Abbott Recent Developments and Future Plans
Figure 22. Siemens Healthcare Recent Developments and Future Plans
Figure 23. DiaSorin Recent Developments and Future Plans
Figure 24. Roche Recent Developments and Future Plans
Figure 25. Beckman Coulter Recent Developments and Future Plans
Figure 26. PerkinElmer Recent Developments and Future Plans
Figure 27. Tosoh Recent Developments and Future Plans
Figure 28. Ortho Clinical Recent Developments and Future Plans
Figure 29. Fujirebio Recent Developments and Future Plans
Figure 30. Mediwatch (LABORIE) Recent Developments and Future Plans
Figure 31. BodiTech Recent Developments and Future Plans
Figure 33. Global Prostate-Specific Antigen (PSA) Test Revenue Share by Players in 2020
Figure 34. Prostate-Specific Antigen (PSA) Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Prostate-Specific Antigen (PSA) Test Revenue Market Share in 2020
Figure 36. Global Top 10 Players Prostate-Specific Antigen (PSA) Test Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Prostate-Specific Antigen (PSA) Test Revenue Share by Type in 2020
Figure 39. Global Prostate-Specific Antigen (PSA) Test Market Share Forecast by Type (2021-2026)
Figure 40. Global Prostate-Specific Antigen (PSA) Test Revenue Share by Application in 2020
Figure 41. Global Prostate-Specific Antigen (PSA) Test Market Share Forecast by Application (2021-2026)
Figure 42. North America Prostate-Specific Antigen (PSA) Test Sales Market Share by Type (2016-2026)
Figure 43. North America Prostate-Specific Antigen (PSA) Test Sales Market Share by Application (2016-2026)
Figure 44. North America Prostate-Specific Antigen (PSA) Test Revenue Market Share by Country (2016-2026)
Figure 45. United States Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Prostate-Specific Antigen (PSA) Test Sales Market Share by Type (2016-2026)
Figure 49. Europe Prostate-Specific Antigen (PSA) Test Sales Market Share by Application (2016-2026)
Figure 50. Europe Prostate-Specific Antigen (PSA) Test Revenue Market Share by Country (2016-2026)
Figure 51. Germany Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Prostate-Specific Antigen (PSA) Test Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Prostate-Specific Antigen (PSA) Test Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Prostate-Specific Antigen (PSA) Test Revenue Market Share by Region (2016-2026)
Figure 59. China Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Prostate-Specific Antigen (PSA) Test Sales Market Share by Type (2016-2026)
Figure 66. South America Prostate-Specific Antigen (PSA) Test Sales Market Share by Application (2016-2026)
Figure 67. South America Prostate-Specific Antigen (PSA) Test Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Prostate-Specific Antigen (PSA) Test Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Prostate-Specific Antigen (PSA) Test Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Prostate-Specific Antigen (PSA) Test Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Prostate-Specific Antigen (PSA) Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source

以下、関連資料のご紹介

世界の抗原皮膚検査市場 2021：企業別、地域別、種類・用途別

Global Antigen Skin Test Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z00977 2021年4月 105Pages
当調査資料では、抗原皮膚検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗原皮膚検査の種類別市場規模（真菌感染症、細菌感染症、寄生虫感染症）、用途別市場規模（病院、診療所）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア...

世界の抗核抗体（ANA）検査市場 2021：企業別、地域別、種類・用途別

Global Antinuclear Antibody (ANA) Test Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z01000 2021年4月 108Pages
当調査資料では、抗核抗体（ANA）検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗核抗体（ANA）検査の種類別市場規模（試薬・アッセイキット、システム、ソフトウェア・サービス）、用途別市場規模（病院、臨床検査室、医師室検査室、その他）、地域別市場...

世界の抗原皮膚検査市場規模・現状・予測（2021年-2027年）

Global Antigen Skin Test Market Size, Status and Forecast 2021-2027
QYR2104Z0390 2021年4月 92Pages
QYResearch社発行の本調査資料では、抗原皮膚検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（真菌感染症、細菌感染症、寄生虫感染症）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界の比吸収率試験システム市場 2021：企業別、地域別、種類・用途別

Global Specific Absorption Rate Test System Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z13045 2021年4月 107Pages
当調査資料では、比吸収率試験システムのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。比吸収率試験システムの種類別市場規模（従来式SAR測定システム、高速SAR測定システム）、用途別市場規模（試験研究所、無線会社、その他）、地域別市場規模（北米、アメリカ...

世界のポイントオブケア（POCT）検査市場 2021：企業別、地域別、種類・用途別

Global Point of Care Testing Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z11083 2021年4月 103Pages
当調査資料では、ポイントオブケア（POCT）検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ポイントオブケア（POCT）検査の種類別市場規模（血糖値検査、妊娠検査、感染因子検査、心臓マーカー検査、血液化学検査、その他）、用途別市場規模（病院、在宅ケ...

世界の抗原検出検査市場規模・現状・予測（2021年-2027年）

Global Antigen Detection Test Market Size, Status and Forecast 2021-2027
QYR2104Z0389 2021年4月 90Pages
QYResearch社発行の本調査資料では、抗原検出検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ラピッドインフルエンザ診断検査、蛍光抗体法）、用途別市場規模（病院、POCT、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界の抗原検出検査市場規模・現状・予測（2021年-2027年）

世界の感染症ポイントオブケア（POCT）検査市場 2021：企業別、地域別、種類・用途別

Global Point of Care Testing for Infectious Disease Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z11084 2021年4月 106Pages
当調査資料では、感染症ポイントオブケア（POCT）検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。感染症ポイントオブケア（POCT）検査の種類別市場規模（免疫学的検査、病原体核酸検査）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、...

世界のポイントオブケア感染症診断/検査市場 2021：企業別、地域別、種類・用途別

Global Point-of-Care Infectious Disease Diagnostics/Testing Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z11087 2021年4月 123Pages
当調査資料では、ポイントオブケア感染症診断/検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ポイントオブケア感染症診断/検査の種類別市場規模（HIV POC、クロストリジウム・ディフィシルPOC、HBV POC、肺炎・ストレプトコッカス関連感染症、...

世界のDNA診断/検査市場 2021：企業別、地域別、種類・用途別

Global DNA Diagnostics/Testing Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z04571 2021年4月 109Pages
当調査資料では、DNA診断/検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。DNA診断/検査の種類別市場規模（PCR診断、NGS DNA診断、In-situハイブリダイゼーション診断、マイクロアレイ診断）、用途別市場規模（腫瘍診断・組織病理、アイデ...

世界の抗原皮膚検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Antigen Skin Test Market The global Antigen Skin Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a…
世界の抗原皮膚検査市場 2021：企業別、地域別、種類・用途別 The Antigen Skin Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …
世界の比吸収率試験システム市場 2021：企業別、地域別、種類・用途別 The Specific Absorption Rate Test System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
世界の抗原検出検査市場規模・現状・予測（2021年-2027年） Antigen detection test is a rapid diagnostic test suitable for point-of-care testing that directly detects the presence or absence of an antigen. Market Analysis and Insights: Global Antigen Detection Test Market The global Antigen Detection Test market size is projected to reach US$ XX million by 2…
世界の抗原検出検査市場規模・現状・予測（2021年-2027年） Antigen detection test is a rapid diagnostic test suitable for point-of-care testing that directly detects the presence or absence of an antigen. Market Analysis and Insights: Global Antigen Detection Test Market The global Antigen Detection Test market size is projected to reach US$ XX million by 2…